Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies. - Wikidata - wikimedia - TriplyDB

Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.

Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.

http://www.wikidata.org/entity/Q33818302

about

The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform Completeness of prescription information in US commercial claims databases Evidence of sample use among new users of statins: implications for pharmacoepidemiology.Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).Outcomes of nails versus plates for humeral shaft fractures: a Medicare cohort study.Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs.Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer.Long-term use of bisphosphonates in osteoporosis.Influence of refill adherence method when comparing level of adherence for different dosing regimens.Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patients.

P2860

Q28488248-B3726218-E40F-467C-A543-44ACD229B0E9 Q33575568-F0BD912C-1DA7-4E29-A84B-43B8747D1AD7 Q34077639-4D65BC8A-7612-4B68-A3A0-216212BA1F87 Q34462218-EA84734B-913B-455D-9514-5D0551E8FA20 Q36101159-DDE1FE6F-6327-4BB8-B1F6-2B99FD37A0B2 Q36284450-0F5E6D60-872A-4B0C-9AD4-3A3BECCC864B Q39162467-216572AF-C390-48DF-8686-C612E812D442 Q39348693-2D91F604-8F27-4B01-A53D-E9EC37C6AECF Q44131390-0E3ACFA2-2F71-4F29-ACBE-E5AD7263C14D Q51257862-71C486E9-125D-4DBA-BC46-45018A2C386C

P2860

Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.

http://www.wikidata.org/entity/Q33818302

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Potential and pitfalls of usin ...... ety of osteoporosis therapies.

@ast

Potential and pitfalls of usin ...... ety of osteoporosis therapies.

@en

type

label

Potential and pitfalls of usin ...... ety of osteoporosis therapies.

@ast

Potential and pitfalls of usin ...... ety of osteoporosis therapies.

@en

prefLabel

Potential and pitfalls of usin ...... ety of osteoporosis therapies.

@ast

Potential and pitfalls of usin ...... ety of osteoporosis therapies.

@en

P1433

Q33818302-D5EFA276-953D-4C7A-83EC-4862578B9BBC

P1476

Q33818302-AD4649CB-A256-4D60-A794-0F711E0EF3BA

P2093

Q33818302-120F7055-C123-4D47-A656-62D9F16E483A

Q33818302-3092B14E-6843-4C22-92C7-C7A37FE9A53A

Q33818302-7A32B314-91BF-42A6-A568-E57256A8F7C9

Q33818302-85FEF046-30DB-4A52-BDCD-313042172C4F

Q33818302-F4148B8C-0A02-40A8-BB9C-5C0BBDC2BA85

P2860

Q33818302-090DAA26-4931-4543-B3F8-7831F1AFADB3

Q33818302-1698A7DE-56CA-4718-AD72-E488D302E541

Q33818302-183B7BD3-1E2D-40C4-941E-9C71DF3FBF98

Q33818302-2253748F-E676-4052-9FAD-E09BEA0E6957

Q33818302-243F0733-BAEF-40A3-ADF2-DE6BFD6D66AA

Q33818302-25D86351-19F2-4B7B-A6AA-BFD2823205F7

Q33818302-3163BE7C-ECD9-4EB9-9D8E-58A0AD539316

Q33818302-34EA15B8-2AEE-4805-B860-B800BF5CA1B8

Q33818302-48EBE37D-88D9-4D29-9FF2-8B089AEBB2E9

Q33818302-4A7FA377-90DD-4ED5-95D5-4BEDBF5F0194

P2888

Q33818302-4A9865DD-8AF8-4FB8-81CE-1B1DBF8BE33D

P304

Q33818302-9A1AB063-E23F-4F5B-B709-438DD0164A9F

P31

Q33818302-B7D21F00-17F9-4AD4-88F2-94E6A6976FB4

P356

Q33818302-5C8DFB65-A4CC-4365-AFC7-8576965C6A50

P433

Q33818302-FAD4E6CB-2BF1-437D-856D-93F8DF48E67C

P478

Q33818302-5DAD720F-8E99-41F2-BB5B-BC8F6EFCAA06

P50

Q33818302-00106E2B-0F79-4EE9-8408-69E4DF4C79FF

P577

Q33818302-842CB54D-C378-4A47-B44A-510A192BB7E3

P6179

Q33818302-6A3E8E8E-F12A-4B09-9B84-AA7F2CCF0527

P698

Q33818302-3E9E449F-2C1E-4CB3-B84B-EB0D233B7448

P356

S11926-011-0168-8

P1433

Current Rheumatology Reports

P1476

Potential and pitfalls of usin ...... fety of osteoporosis therapies

@en

P2093

Elizabeth Delzell

http://www.w3.org/2001/XMLSchema#string

Huifeng Yun

http://www.w3.org/2001/XMLSchema#string

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Kenneth G Saag

http://www.w3.org/2001/XMLSchema#string

Meredith Kilgore

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a comorbidity index using physician claims data.

Medicare part D data: major changes on the horizon.

Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example.

Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results.

Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

Linking the Iowa Women's Health Study cohort to Medicare data: linkage results and application to hip fracture.

Developments in post-marketing comparative effectiveness research

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

P2888

s11926-011-0168-8

P304

273-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-011-0168-8

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Nicole C. Wright

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002775100

http://www.w3.org/2001/XMLSchema#string

P698

21312073

http://www.w3.org/2001/XMLSchema#string